TP53 and EGFR mutation occurred in a mutually exclusive pattern in ISPs, whereas the ISP-associated carcinomas harbored simultaneously an ISP-typical EGFR exon 20 mutation and a TP53 mutation in 40% of cases (4/10). Here, EGFR is linked to carcinoma.